Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

MS-China June 2026 Rebalance: Post-Implementation Review

MS-China Sep 2026 Index Rebalance Forecast

MS-China June 2026 Rebalance: Post-Announcement Trading Pattern Analysis

MS-China March 2026 Rebalance: Post-Event Review

MS-China Index Earning Revision (Mar): PDD, UNITED NOVA TECHNOLOGY, MEITUAN, TENCENT, ALIBABA

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Index Rebalance

Yangtze Optical Fibre & Cable / Index Rebalance

Yangtze Optical Fibre & Cable (601869 CH)

<ul>
<li>MSCI announced the quarterly review results on 12 May 2026. As the cycle enters implementation, this note updates the stock setup.</li>
<li>ADD weakness is broad, with CH Mid-vel and CH Low-vel both failing to build bridge support.</li>
<li>DELETEs already sold off, but HK High-vel DELETE still has the weakest first-week implementation profile.</li>
</ul>


MSCI announced the quarterly review results on 12 May 2026. As the cycle enters implementation, this note updates the stock setup.
ADD weakness is broad, with CH Mid-vel and CH Low-vel both failing to build bridge support.
DELETEs already sold off, but HK High-vel DELETE still has the weakest first-week implementation profile.


COSCO SHIPPING Energy Transportation (1138 HK)

China CITIC Financial Asset Management (2799 HK)

Shandong Weigao Group Medical Polymer (1066 HK)

Jiangsu Yuyue Medical Equipment & Supply A (002223 CH)

Jiangsu Yuyue Medical Equipment & Supply A

Jiangsu King's Luck Brewery JS (603369 CH)

China Railway Signal & Communi (688009 CH)

Guangzhou Baiyunshan Pharmaceu (600332 CH)

Everdisplay Optronics Shanghai (688538 CH)

Sichuan Biokin Pharmaceutical (688506 CH)

Hunan Yuneng New Energy Battery Material (301358 CH)

MS-China June 2026 Rebalance: Pre-Implementation Update